Deflazacort and Prednisolone: Key Differences
Deflazacort may be preferred over prednisolone when weight gain and behavioral issues are primary concerns, though it carries higher risks for cataracts and potentially greater effects on bone health and growth. 1
Pharmacological Differences
Dosing Equivalence
The equipotency ratio between these corticosteroids is not straightforward. While commonly assumed to be 1.2:1 (deflazacort:prednisolone), research shows significant variability:
- Standard dosing for DMD: Deflazacort 0.9 mg/kg/day vs Prednisone 0.75 mg/kg/day 1
- Dose caps: Deflazacort 36-39 mg/day vs Prednisone 30-40 mg/day at 40 kg body weight 1
- Research demonstrates equipotency ratios ranging from 1.14 to 2.77 depending on the measured parameter (cortisol suppression, osteocalcin, lymphocyte suppression) 2
Pharmacokinetic Properties
Deflazacort is a prodrug rapidly converted to its active metabolite 21-desDFZ by esterases, then further metabolized by CYP3A4 3. Key differences include:
- Lipid solubility: Deflazacort has different lipid solubility characteristics affecting tissue distribution 4
- P-glycoprotein substrate: Deflazacort is a strong P-gp substrate, limiting CNS penetration compared to prednisolone 5
- Protein binding: 21-desDFZ is approximately 40% protein-bound 3
- Elimination: Predominantly urinary (68%), completed within 24 hours 3
Prednisolone shows 70-90% protein binding and 2-4 hour plasma half-life 6
Efficacy Comparison in DMD
Deflazacort demonstrates superior functional preservation in multiple analyses:
- 6-minute walk distance: Deflazacort showed 28.3-39.5 meter advantage over prednisone/prednisolone at 48 weeks 7, 8
- Timed function tests: Significantly better performance on 4-stair climb (2.3-2.9 seconds) and 4-stair descend 7, 9
- North Star Ambulatory Assessment: 2.9 point advantage with deflazacort 8
However, these differences come from post-hoc analyses and meta-analyses rather than head-to-head randomized trials 9, 8.
Side Effect Profile: Critical Distinctions
Advantages of Deflazacort
Weight gain and behavioral issues are significantly less problematic with deflazacort 1:
- When weight gain or behavioral problems become unmanageable on prednisone, switch to deflazacort 1
- Lower incidence of overall adverse events: 16.5% (deflazacort) vs 20.5% (prednisone) 10
- Less impact on glucose metabolism in some studies 10
Disadvantages of Deflazacort
Cataracts are a specific concern requiring annual ophthalmological monitoring 1:
- If cataracts develop affecting vision, consider switching from deflazacort to prednisone 1
- Potentially greater effects on bone density and growth parameters 4
- Higher cost (particularly relevant before generic availability)
Shared Side Effects
Both require identical monitoring for 1:
- Bone demineralization (annual DEXA, vitamin D monitoring)
- Hypertension
- Immune/adrenal suppression
- Gastroesophageal reflux
- Growth retardation and delayed puberty
Clinical Decision Algorithm
Start with prednisone 0.75 mg/kg/day as first-line UNLESS:
- Pre-existing obesity or significant weight concerns → Start deflazacort 0.9 mg/kg/day 1
- Pre-existing behavioral issues (ADHD, emotional lability) → Start deflazacort 0.9 mg/kg/day 1
Switch from prednisone to deflazacort if:
Switch from deflazacort to prednisone if:
- Cataracts develop affecting vision 1
- Severe bone health concerns despite optimization
Important Caveats
The minimum effective daily dose is approximately 0.3 mg/kg/day for prednisone 1. When side effects are unmanageable:
- Reduce dose by 25-33% and reassess in 1 month 1
- If still problematic, consider switching corticosteroid type 1
- If weight/behavior are main issues, deflazacort is preferred 1
- Only abandon corticosteroid therapy after attempting dose reduction AND regimen change 1
Both corticosteroids should be continued even when non-ambulatory for benefits on scoliosis, pulmonary function, and cardiac function 1.